2025. Surgery Following Induction (Neoadjuvant) Therapy with Pembrolizumab in Lung Adenocarcinoma with High PD-L1 Expression. Respirar. 17, 1 (Oct. 2025), 68–75. DOI:https://doi.org/10.55720/respirar.17.1.6.